Patent Number: 8,877,191

Title: Antibodies to the PcrV antigen of Pseudomonas aeruginosa

Abstract: The current invention provides high-affinity antibodies to the Pseudomonas aeruginosa PcrV protein that have reduced immunogenicity when administered to treat Pseudomonas aeruginosa infections.

Inventors: Bebbington; Christopher R. (San Mateo, CA), Luehrsen; Kenneth (Half Moon Bay, CA), Yarranton; Geoffrey T. (Burlingame, CA), Baer; Mark (San Francisco, CA)

Assignee: KaloBios Pharmaceuticals, Inc.

International Classification: A61K 39/104 (20060101); A61K 39/395 (20060101)

Expiration Date: 2019-11-04 0:00:00